Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion type Assertion NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_head.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion wasGeneratedBy ECO_0000203 NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_provenance.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion wasDerivedFrom befree-20150227 NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_provenance.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion SIO_000772 20059341 NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_provenance.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion evidence source_evidence_literature NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_provenance.
- NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_assertion description "[Clinical trials are currently ongoing with agents targeting the tyrosine kinase domain of MET in sporadic and hereditary forms of papillary kidney cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803192.RAD5J6cCeICm-X8LGY1LZVbOQ64Id5-sj13pDy-XafkiY130_provenance.